scholarly article | Q13442814 |
P50 | author | Mel Krajden | Q6810759 |
Gaston De Serres | Q86870133 | ||
Jonathan B Gubbay | Q87716515 | ||
Danuta M. Skowronski | Q111259505 | ||
Romy Olsha | Q114718263 | ||
Suzana Sabaiduc | Q114718265 | ||
Tracy Chan | Q114718286 | ||
Siobhan Leir | Q114718287 | ||
James A Dickinson | Q42422634 | ||
Matthew A Croxen | Q56491447 | ||
Michelle Murti | Q60313150 | ||
Yan Li | Q69032212 | ||
Nathalie Bastien | Q69032280 | ||
Hugues Charest | Q86870110 | ||
P2860 | cites work | Diversifying Selection Analysis Predicts Antigenic Evolution of 2009 Pandemic H1N1 Influenza A Virus in Humans. | Q27320929 |
The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. | Q30329363 | ||
Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model | Q30430458 | ||
Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties | Q34055754 | ||
Selection of antigenically advanced variants of seasonal influenza viruses | Q36116332 | ||
Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season | Q38415770 | ||
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 | ||
Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016. | Q39884414 | ||
Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. | Q42237299 | ||
Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada | Q47613621 | ||
Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018. | Q49204982 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Canada | Q16 |
vaccine-preventable diseases | Q7907939 | ||
P577 | publication date | 2019-01-01 | |
P1433 | published in | Eurosurveillance | Q14565070 |
P1476 | title | Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019 | |
P478 | volume | 24 |
Q91761667 | A case of reassortant seasonal influenza A(H1N2) virus, Denmark, April 2019 |
Q92706811 | A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy) |
Q89655390 | Assessing antigenic drift and phylogeny of influenza A (H1N1) pdm09 virus in Kenya using HA1 sub-unit of the hemagglutinin gene |
Q64054477 | Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: possible cohort effect following the 2009 influenza pandemic |
Q64087276 | Co-circulation of influenza A(H1N1)pdm09 and influenza A(H3N2) viruses, World Health Organization (WHO) European Region, October 2018 to February 2019 |
Q64271987 | Early season estimate of influenza vaccination effectiveness against influenza hospitalisation in children, Hong Kong, winter influenza season 2018/19 |
Q94662614 | Effectiveness of quadrivalent influenza vaccine in pregnant women and infants, 2018-2019 |
Q92942088 | Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019 |
Q91636311 | Heterogeneity of Circulating Influenza Viruses and Their Impact on Influenza Virus Vaccine Effectiveness During the Influenza Seasons 2016/17 to 2018/19 in Austria |
Q92732609 | Intense interseasonal influenza outbreaks, Australia, 2018/19 |
Q64118690 | Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019 |
Q64243916 | Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019 |
Q89881062 | Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020 |
Q64087253 | Novel influenza A(H1N2) seasonal reassortant identified in a patient sample, Sweden, January 2019 |
Q97092978 | Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019 |
Q90948756 | Protection provided by influenza vaccine against influenza-related hospitalisation in ≥65 year olds: Early experience of introduction of a newly licensed adjuvanted vaccine in England in 2018/19 |
Q91724850 | Should individuals use influenza vaccine effectiveness studies to inform their decision to get vaccinated? |